Pathways of hepatic and renal damage through non‐classical activation of the renin‐angiotensin system in chronic liver disease

Physiology of Local Renin-Angiotensin Systems

Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · see citing works

Niere und Kreislauf1

Tigerstedt, R., & Bergman, P. Q. (1898) · Skandinavisches Archiv Für Physiologie · doi:10.1111/j.1748-1716.1898.tb00272.x · Cited by 797 · see citing works

Management of Cirrhosis and Ascites

Ginès, P., Cárdenas, A., Arroyo, V., & Rodés, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035021 · Cited by 768 · see citing works

High-affinity enkephalin-degrading peptidase in brain is increased after morphine

Malfroy, B., Swerts, J.-P., Gruaz‐Guyon, A., Roques, B. P., & Schwartz, J. (1978) · Nature · doi:10.1038/276523a0 · Cited by 642 · see citing works

NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis

Bataller, R. A., Schwabe, R. F., Choi, Y. H., Yang, L., Paik, Y. H., Lindquist, J. N., Qian, T., Schoonhoven, R., Hagedorn, C. H., Lemasters, J. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18212 · Cited by 566 · see citing works

Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones 1

Erdös, E. G., & Skidgel, R. A. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.2.2521610 · Cited by 558 · see citing works

Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure

Xu, J., Li, G., Wang, P., Velázquez, H., Yao, X., Li, Y., Wu, Y., Peixoto, A. J., Crowley, S. T., & Désir, G. V. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24066 · Cited by 464 · see citing works

Evidence That the Angiotensin IV (AT4) Receptor Is the Enzyme Insulin-regulated Aminopeptidase

Albiston, A. L., McDowall, S. G., Matsacos, D. J., Sim, P. S.-L., Clune, E. F., Mustafa, T., Lee, J., Mendelsohn, F. A. O., Simpson, R. J., Connolly, L., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100512200 · Cited by 462 · see citing works

Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for nonproteolytic activation of prorenin

Ichihara, A., Hayashi, M., Kaneshiro, Y., Suzuki, F., Nakagawa, T., Tada, Y., Koura, Y., Nishiyama, A., Okada, H., Uddin, M. N., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21398 · Cited by 455 · see citing works

Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms

Huang, Y., Wongamorntham, S., Kasting, J., McQuillan, D. J., Owens, R. T., Yu, L. H., Noble, N. A., & Border, W. A. (2005) · Kidney International · doi:10.1038/sj.ki.5000011 · Cited by 423 · see citing works

The Cardiac Renin-Angiotensin System

Dostal, D. E., & Baker, K. M. (1999) · Circulation Research · doi:10.1161/01.res.85.7.643 · Cited by 400 · see citing works

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats

Yoshiji, H., Kuriyama, S., Yoshii, J., Ikenaka, Y., Noguchi, R., Nakatani, T., Tsujinoue, H., & Fukui, H. (2001) · Hepatology · doi:10.1053/jhep.2001.28231 · Cited by 397 · see citing works

The substance causing renal hypertension

Braun-Menendez, E., Fasciolo, J. C., Leloir, L. F., & Muñoz, J. M. (1940) · The Journal of Physiology · doi:10.1113/jphysiol.1940.sp003850 · Cited by 365 · see citing works

Endothelins in the normal and diseased kidney

Kohan, D. E. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90004-4 · Cited by 355 · see citing works

Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II

Bataller, R. A., Sancho‐Bru, P., Ginès, P., Lora, J. M., Al-Garawi, A. A., Solé, M., Colmenero, J., Nicolás, J. M., Jiménez, W., Weich, N. S., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00695-4 · Cited by 352 · see citing works

Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2

Paizis, G., Tikellis, C., Cooper, M. E., Schembri, J. M., Lew, R. A., Smith, A. I., Shaw, T., Warner, F. J., Zuilli, A., Burrell, L. M., et al. (2005) · Gut · doi:10.1136/gut.2004.062398 · Cited by 334 · see citing works

Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients.

Pinzani, M., Failli, P., Ruocco, C., Casini, A., Milani, S., Baldi, E., Giotti, A., & Geñtilini, P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115905 · Cited by 328 · see citing works

International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli

Karnik, S. S., Ünal, H., Kemp, J. R., Tirupula, K. C., Eguchi, S., Vanderheyden, P., & Thomas, W. G. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010454 · Cited by 302 · see citing works

Angiotensin-Converting Enzyme Inhibition Attenuates the Progression of Rat Hepatic Fibrosis

Jonsson, J. R., Clouston, A. D., Ando, Y., Kelemen, L., Horn, M. J., Adamson, M., Purdie, D. M., & Powell, E. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25480 · Cited by 296 · see citing works

Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors

Bosnyak, S., Jones, E. S., Christopoulos, A., Aguilar, M., Thomas, W. G., & Widdop, R. E. (2011) · Clinical Science · doi:10.1042/cs20110036 · Cited by 288 · see citing works

The natriuretic-peptide family

Wilkins, M. R., Redondo, J., & Brown, L. A. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07424-7 · Cited by 244 · see citing works

Circulating Exosomes Induced by Cardiac Pressure Overload Contain Functional Angiotensin II Type 1 Receptors

Pironti, G., Strachan, R. T., Abraham, D., Yu, S. M.-W., Chen, M., Chen, W., Hanada, K., Mao, L., Watson, L. J., & Rockman, H. A. (2015) · Circulation · doi:10.1161/circulationaha.115.015687 · Cited by 238 · see citing works

Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells

Huang, Y., Noble, N. A., Zhang, J., Xu, C., & Border, W. A. (2007) · Kidney International · doi:10.1038/sj.ki.5002243 · Cited by 235 · see citing works

Determinants of interindividual variation of renin and prorenin concentrations

Danser, A. H. J., Derkx, F. H. M., Schalekamp, M. A. D. H., Hense, H., Riegger, G. A. J., & Schunkert, H. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816060-00017 · Cited by 232 · see citing works

Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis

Hirose, A., Ono, M., Saibara, T., Nozaki, Y., Masuda, K., Yoshioka, A., Takahashi, M., Akisawa, N., Iwasaki, S., Oben, J. A., et al. (2007) · Hepatology · doi:10.1002/hep.21638 · Cited by 230 · see citing works

Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor

Batenburg, W. W., Krop, M., Garrelds, I. M., VRIES, R. D., de Bruin, R. J., Burcklé, C., Müller, D. N., Bäder, M., Nguyen, G., & Danser, A. J. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f05bae · Cited by 222 · see citing works

Role of NADPH Oxidases in Liver Fibrosis

Paik, Y., Kim, J., Aoyama, T., Minicis, S. D., Bataller, R. A., & Brenner, D. A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5619 · Cited by 221 · see citing works

Cytochrome P-450 metabolites mediate extracellular Ca(2+)-induced inhibition of apical K+ channels in the TAL

Wang, W. H., Lu, M., & Hébert, S. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.1.c103 · Cited by 218 · see citing works

Konstitution des Aldosterons, des neuen Mineralocorticoids

SIMPSON, S. A., Tait, J. F., Wettstein, A., Neher, R., Euw, J. V., Schindler, O., & Reichstein, T. (1954) · Cellular and Molecular Life Sciences · doi:10.1007/bf02158515 · Cited by 206 · see citing works

Effect of Losartan, An Angiotensin Ii Receptor Antagonist, on Portal Pressure in Cirrhosis

Schneider, A. W., Kalk, J. F., & Klein, C. (1999) · Hepatology · doi:10.1002/hep.510290203 · Cited by 202 · see citing works

Role of angiotensin II in the altered renal function of congestive heart failure.

Ichikawa, I., Pfeffer, J. M., Pfeffer, M. A., Hostetter, T. H., & Brenner, B. M. (1984) · Circulation Research · doi:10.1161/01.res.55.5.669 · Cited by 192 · see citing works

Up-regulation of components of the renin-angiotensin system in the bile duct–ligated rat liver

Paizis, G., Cooper, M. E., Schembri, J. M., Tikellis, C., Burrell, L. M., & Angus, P. (2002) · Gastroenterology · doi:10.1053/gast.2002.36561 · Cited by 188 · see citing works

Isolation and identification of proangiotensin-12, a possible component of the renin–angiotensin system

Nagata, S., Kato, J., Sasaki, K., Minamino, N., Eto, T., & Kitamura, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.146 · Cited by 182 · see citing works

Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis.

González-Abraldes, J., Albillos, A., Bañares, R., Del Arbol, L. R., Moitinho, E., Rodríguez, C., González, M., Escorsell, A., García-Pagán, J. C., & Bosch, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.26288 · Cited by 165 · see citing works

The Broad Substrate Specificity of Human Angiotensin I Converting Enzyme

Skidgel, R. A., & Erdös, E. G. (1987) · Clinical and Experimental Hypertension · doi:10.3109/10641968709164184 · Cited by 161 · see citing works

Renin/prorenin receptors

Nguyen, G. (2006) · Kidney International · doi:10.1038/sj.ki.5000265 · Cited by 146 · see citing works

Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension

Schepke, M., Werner, E., Biecker, E., Schiedermaier, P., Heller, J., Neef, M., Caselmann, W. H., Sauerbruch, T., Stoffel‐Wagner, B., & Hofer, U. (2001) · Gastroenterology · doi:10.1053/gast.2001.26295 · Cited by 142 · see citing works

ACE2 in Brain Physiology and Pathophysiology: Evidence from Transgenic Animal Models

Alenina, N. V., & Bäder, M. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2679-4 · Cited by 137 · see citing works

Renin–angiotensin–aldosterone inhibitors in the reduction of portal pressure: A systematic review and meta-analysis

Tandon, P., Abraldeṣ, J. G., Berzigotti, A., García‐Pagán, J. C., & Bosch, J. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.013 · Cited by 134 · see citing works

Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice #

Österreicher, C. H., Taura, K., Minicis, S. D., Seki, E., Penz-Österreicher, M., Kodama, Y., Kluwe, J., Schuster, M., Oudit, G. Y., Penninger, J. M., et al. (2009) · Hepatology · doi:10.1002/hep.23104 · Cited by 132 · see citing works

Nonclassical Renin‐Angiotensin System and Renal Function

Chappell, M. C. (2012) · Comprehensive physiology · doi:10.1002/cphy.c120002 · Cited by 128 · see citing works

Angiotensin II Activates IκB Kinase Phosphorylation of RelA at Ser536 to Promote Myofibroblast Survival and Liver Fibrosis

Oakley, F., Teoh, V. W. Y., Ching-A-Sue, G., Bataller, R. A., Colmenero, J., Jonsson, J. R., Eliopoulos, A. G., Watson, M. R., Manas, D., & Mann, D. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.081 · Cited by 127 · see citing works

The amino terminal amino acid sequence of human angiotensinogen

Tewksbury, D. A., Dart, R. A., & Travis, J. W. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(81)90762-2 · Cited by 116 · see citing works

Acute Effects of Captopril on Systemic and Renal Hemodynamics and on Renal Function in Cirrhotic Patients With Ascites

Pariente, E. A., Bataille, C., Bercoff, E., & Lebrec, D. (1985) · Gastroenterology · doi:10.1016/s0016-5085(85)80088-3 · Cited by 106 · see citing works

Cannabinoid Receptor 1 Participates in Liver Inflammation by Promoting M1 Macrophage Polarization via RhoA/NF-κB p65 and ERK1/2 Pathways, Respectively, in Mouse Liver Fibrogenesis

Tian, L., Li, W., Yang, L., Chang, N., Fan, X., Ji, X., Xie, J., Yang, L., & Li, L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01214 · Cited by 102 · see citing works

Extracellular calcium antagonizes forskolin-induced aquaporin 2 trafficking in collecting duct cells

Procino, G., Carmosino, M., Tamma, G., Gouraud, S. S., Laera, A., Riccardi, D., Svelto, M., & Valenti, G. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.66036.x · Cited by 100 · see citing works

Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat

Ferrario, C. M., Averill, D. B., Brosnihan, K. B., Chappell, M. C., Iskandar, S. S., Dean, R. H., & Diz, D. I. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00559.x · Cited by 98 · see citing works

Activation of the Mas Receptor by Angiotensin-(1–7) in the Renin–Angiotensin System Mediates Mesenteric Vasodilatation in Cirrhosis

Grace, J., Klein, S., Herath, C. B., Granzow, M., Schierwagen, R., Masing, N., Walther, T., Sauerbruch, T., Burrell, L. M., Angus, P., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.06.036 · Cited by 94 · see citing works

Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver

Gentilini, P., Romanelli, R. G., Villa, G. L., Maggiore, Q., Pesciullesi, E., Cappelli, G., Raggi, V. C., Foschi, M., Marra, F., Pinzani, M., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90431-b · Cited by 94 · see citing works

An evolving story of angiotensin-II-forming pathways in rodents and humans

Ferrario, C. M., Ahmad, S., Nagata, S., Simington, S., Varagić, J., Kon, N. D., & Dell’Italia, L. J. (2013) · Clinical Science · doi:10.1042/cs20130400 · Cited by 92 · see citing works

Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension

Shim, K. Y., Eom, Y. W., Kim, M. Y., Kang, S. H., & Baik, S. K. (2018) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2017.317 · Cited by 90 · see citing works

Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullin

Lisý, O., Jougasaki, M., Schirger, J. A., Chen, H. H., Barclay, P. T., & Burnett, J. C. J. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.275.3.f410 · Cited by 89 · see citing works

Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis

Nabeshima, Y., Tazuma, S., Kanno, K., Hyogo, H., Iwai, M., Horiuchi, M., & Chayama, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.183 · Cited by 87 · see citing works

Pathways of angiotensin‐(1–7) metabolism in the kidney

Chappell, M. C., Allred, A. J., & Ferrario, C. M. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.suppl_1.22 · Cited by 83 · see citing works

Circulating versus tissue renin-angiotensin system: On the origin of (pro)renin

Krop, M., & Danser, A. H. J. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0022-1 · Cited by 81 · see citing works

AT1 receptor antagonist Candesartan in selected cirrhotic patients: Effect on portal pressure and liver fibrosis markers

Debernardi-Venon, W., Martini, S., Biasi, F., Vizio, B., Termine, A., Poli, G., Brunello, F., Alessandria, C., Bonardi, R., Saracco, G. M., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.017 · Cited by 81 · see citing works

Mineralocorticoid regulation of cell function: the role of rapid signalling and gene transcription pathways

Ong, G. S. Y., & Young, M. J. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0318 · Cited by 72 · see citing works

Local Angiotensin II-Generating System in Vascular Tissues: The Roles of Chymase.

宮崎, 瑞., & Takai, S. (2001) · Hypertension Research · doi:10.1291/hypres.24.189 · Cited by 69 · see citing works

ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice

Mak, K. Y., Chin, R. A. D., Cunningham, S. C., Habib, M. R., Torresi, J., Sharland, A. F., Alexander, I. E., Angus, P., & Herath, C. B. (2015) · Molecular Therapy · doi:10.1038/mt.2015.92 · Cited by 64 · see citing works

Use of vitamin D in chronic kidney disease patients

Gal‐Moscovici, A., & Sprague, S. M. (2010) · Kidney International · doi:10.1038/ki.2010.113 · Cited by 64 · see citing works

Portal Pressure Response To Losartan Compared With Propranolol in Patients With Cirrhosis

De, B. K., Bandyopadhyay, K., Das, T. K., Das, D., Biswas, P. K., Majumdar, D., Mandal, S. K., Ray, S., & Dasgupta, S. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07497.x · Cited by 62 · see citing works

Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems

Bernardi, M., Gülberg, V., Colantoni, A., Trevisani, F., Gasbarrini, A., & Grebes, A. L. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80025-0 · Cited by 62 · see citing works

Novel insights into the physiology of renalase and its role in hypertension and heart disease

Désir, G. V. (2011) · Pediatric Nephrology · doi:10.1007/s00467-011-1828-7 · Cited by 62 · see citing works

Gene regulation and physiological function of placental leucine aminopeptidase/oxytocinase during pregnancy

Nomura, S., Ito, T., Yamamoto, E., Sumigama, S., Iwase, A., Okada, M., Shibata, K., Ando, H., Ino, K., Kikkawa, F., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.04.006 · Cited by 58 · see citing works

Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity

Baik, S. K., Park, D. H., Kim, M. Y., Choi, Y. J., Kim, H. S., Lee, D. K., Kwon, S. O., Kim, Y. J., Park, J. W., & Chang, S. J. (2003) · Journal of Gastroenterology · doi:10.1007/s00535-003-1222-8 · Cited by 57 · see citing works

Oxidative Stress Causes Renal Angiotensin II Type 1 Receptor Upregulation, Na + /H + Exchanger 3 Overstimulation, and Hypertension

Banday, A. A., & Lokhandwala, M. F. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.162339 · Cited by 55 · see citing works

Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease

Vlachogiannakos, J., TANG, A. K. W., Patch, D., & Burroughs, A. K. (2001) · Gut · doi:10.1136/gut.49.2.303 · Cited by 55 · see citing works

Regulation of renin expression and blood pressure by vitamin D3

Sigmund, C. D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216160 · Cited by 54 · see citing works

Different angiotensin II-forming pathways in human and rat vascular tissues

Takai, S., Sakaguchi, M., Jin, D., Yamada, M., Kirimura, K., & 宮崎, 瑞. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00379-5 · Cited by 54 · see citing works

Acute activation of the calcium-sensing receptor inhibits plasma renin activity in vivo

Atchison, D. K., Ortiz‐Capisano, M. C., & Beierwaltes, W. H. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00238.2010 · Cited by 52 · see citing works

The small molecule drug diminazene aceturate inhibits liver injury and biliary fibrosis in mice

Rajapaksha, I. G., Mak, K. Y., Huang, P., Burrell, L. M., Angus, P., & Herath, C. B. (2018) · Scientific Reports · doi:10.1038/s41598-018-28490-y · Cited by 50 · see citing works

Mineralocorticoid receptor as a therapeutic target in chronic kidney disease and hypertension

Shibata, S., Ishizawa, K., & Uchida, S. (2016) · Hypertension Research · doi:10.1038/hr.2016.137 · Cited by 47 · see citing works

The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis

Wong, F. S.-H., Liu, P. J., & Blendis, L. M. (2002) · Hepatology · doi:10.1053/jhep.2002.33637 · Cited by 44 · see citing works

Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis

Pozzi, M., Grassi, G. M., Redaelli, E., Dell’Oro, R., Ratti, L., Redaelli, A. E., Foglia, G., Lelio, A. D., & Mancia, G. (2001) · Hepatology · doi:10.1053/jhep.2001.29198 · Cited by 41 · see citing works

Neprilysin Inhibitors Potentiate Effects of Bradykinin on B2 Receptor

Deddish, P. A., Marcic, B. M., Tan, F., Jackman, H. L., Chen, Z., & Erdös, E. G. (2002) · Hypertension · doi:10.1161/hy0202.103298 · Cited by 41 · see citing works

High Expression of Neutral Endopeptidase in Idiopathic Diffuse Hyperplasia of Pulmonary Neuroendocrine Cells

Cohen, A. J., King, T. E., Gilman, L. B., Magill, C., & Miller, Y. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.5.9712019 · Cited by 39 · see citing works

Multiple Mechanisms for the Action of Chymase Inhibitors

Takai, S., Jin, D., & Miyazaki, M. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11r11cp · Cited by 38 · see citing works

Divergent pathways for the angiotensin-(1–12) metabolism in the rat circulation and kidney

Westwood, B. M., & Chappell, M. C. (2012) · Peptides · doi:10.1016/j.peptides.2012.03.025 · Cited by 38 · see citing works

Chymase-Dependent Conversion of Big Endothelin-1 in the Mouse in Vivo

Simard, É., Jin, D., Takai, S., Miyazaki, M., Brochu, I., & D’Orléans-Juste, P. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.142992 · Cited by 38 · see citing works

Plasma and Kidney Angiotensin Peptides: Importance of the Aminopeptidase A/Angiotensin III Axis

Wysocki, J. A., Ye, M., & BATLLE, D. C. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpv054 · Cited by 37 · see citing works

The (pro)renin receptor and its interaction partners

Peters, J. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-2005-z · Cited by 35 · see citing works

PURIFICATION OF ANGIOTONIN

Bumpus, F. M., Green, A. A., & Page, I. H. (1954) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65453-5 · Cited by 35 · see citing works

Juxtaglomerular cell CaSR stimulation decreases renin release via activation of the PLC/IP₃pathway and the ryanodine receptor

Ortiz-Capisano, M. C., Reddy, M., Mendez, M., Garvin, J. L., & Beierwaltes, W. H. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00451.2012 · Cited by 35 · see citing works

Future drug discovery in renin-angiotensin-aldosterone system intervention

Tamargo, M., & Tamargo, J. L. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1335301 · Cited by 34 · see citing works

Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis

Klein, S., Herath, C. B., Schierwagen, R., Grace, J., Haltenhof, T., Uschner, F. E., Strassburg, C. P., Sauerbruch, T., Walther, T., Angus, P., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138732 · Cited by 34 · see citing works

Current concepts: renin inhibition in the treatment of hypertension

Gradman, A. H., Pinto, R. D. S., & Kad, R. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.01.003 · Cited by 33 · see citing works

Effects of captopril on hepatic venous pressure and blood flow in patients with liver cirrhosis

Eriksson, L. S., Kågedal, B., & Wahren, J. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90887-8 · Cited by 32 · see citing works

Irbesartan Plus Low-Dose Propranolol Versus Low-Dose Propranolol Alone in Cirrhosis: A Placebo-Controlled, Double-Blind Study

Schepke, M., Wiest, R., Flacke, S., Heller, J., Stoffel‐Wagner, B., Herold, T., Ghauri, M., & Sauerbruch, T. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01759.x · Cited by 31 · see citing works

Angiotensin II stimulates the nuclear translocation of Smad2 and induces PAI-1 mRNA in rat hepatic stellate cells

Kamada, Y. (2003) · Hepatology Research · doi:10.1016/s1386-6346(02)00306-6 · Cited by 29 · see citing works

Loss of angiotensin converting enzyme II (ACE2) accelerates the development of liver injury induced by thioacetamide

Wu, H., Chuang, Y., Huang, C.-P., & Chang, M.-H. (2017) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.17-0053 · Cited by 27 · see citing works

Chymase inhibition attenuates tetrachloride‐induced liver fibrosis in hamsters

Komeda, K., Takai, S., Jin, D., Tashiro, K., Hayashi, M., Tanigawa, N., & Miyazaki, M. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00672.x · Cited by 27 · see citing works

The His-Pro-Phe motif of angiotensinogen is a crucial determinant of the substrate specificity of renin

Nakagawa, T., Akaki, J., Satou, R., Takaya, M., IWATA, H., Katsurada, A., Nishiuchi, K., Ohmura, Y., Suzuki, F., & Nakamura, Y. (2007) · Biological Chemistry · doi:10.1515/bc.2007.026 · Cited by 25 · see citing works

Effects of long-term Irbesartan in reducing portal pressure in cirrhotic patients: comparison with propranolol in a randomised controlled study

Venon, W. D., Baronio, M., Leone, N., Rolfo, E., Fadda, M., Barletti, C., Todros, L., Saracco, G. M., & Rizzetto, M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00443-9 · Cited by 25 · see citing works

Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: A new target to treat portal hypertension?

Sansoe, G. G., Aragno, M., Mastrocola, R., Restivo, F., Mengozzi, G., Smedile, A., Rosina, F., Danni, O., Parola, M., & Rizzetto, M. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.04.017 · Cited by 25 · see citing works

Effects of 1-year administration of olmesartan on portal pressure and TGF-beta1 in selected patients with cirrhosis: a randomized controlled trial

Hidaka, H., Nakazawa, T., Shibuya, A., Minamino, T., Takada, J., Tanaka, Y., Okuwaki, Y., Watanabe, M., & Koizumi, W. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0449-z · Cited by 24 · see citing works

Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension

Kim, J. H., Kim, J. M., Cho, Y. Z., Na, J. H., Kim, H. S., Kim, H. A., Kang, H. W., Baik, S. K., Kwon, S. O., Cha, S. H., et al. (2014) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2014.20.4.376 · Cited by 24 · see citing works

A randomized study of losartan vs propranolol: Effects on hepatic and systemic hemodynamics in cirrhotic patients

Castaño, G. O., Viúdez, P., Riccitelli, M. A., & Sookoian, S. C. (2003) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32156-8 · Cited by 23 · see citing works

TG101348, a selective JAK2 antagonist, ameliorates hepatic fibrogenesis in vivo

Akcora, B. Ö., Dathathri, E., Ortiz‐Perez, A., Gabriël, A. V., Storm, G., Prakash, J., & Bansal, R. (2019) · The FASEB Journal · doi:10.1096/fj.201900215rr · Cited by 22 · see citing works

The ins and outs of angiotensin processing within the kidney

Wilson, B. A., Marshall, A. C., Alzayadneh, E. M., & Chappell, M. C. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00177.2014 · Cited by 21 · see citing works

Pathophysiology of Post Transplant Hypertension in Kidney Transplant: Focus on Calcineurin Inhibitors Induced Oxidative Stress and Renal Sodium Retention and Implications with RhoA/Rho Kinase Pathway

Calò, L. A., Ravarotto, V., Simioni, F., Naso, E., Marchini, F., Bonfante, L., Furian, L., & Rigotti, P. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000483023 · Cited by 21 · see citing works

Effect of enalapril treatment and sclerotherapy of esophageal varices on hepatic hemodynamics in portal hypertension.

Svoboda, P., Ochmann, J., & Kantorová, I. (1992) · PubMed · Cited by 20 · see citing works

Portal pressure, renal function and hormonal profile after acute and chronic captopril treatment in cirrhosis

Ibarra, E. R., Afione, C., Garzón, D. V., Barontini, M., Santos, J. C., & Arrizurieta, E. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf02285088 · Cited by 20 · see citing works

Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullin

Lisý, O., Jougaski, M., Schirger, J., Chen, H., Barclay, P. T., & Burnett, J. (1998) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(98)90067-7 · Cited by 20 · see citing works

Effects of Renin-Angiotensin System Inhibitors on Renal Expression of Renalase in Sprague-Dawley Rats Fed With High Salt Diet

Wang, Y., Xie, B.-Q., Gao, W., Yan, D.-Y., Zheng, W., Lv, Y.-B., Cao, Y. M., Hu, J., Yuan, Z., & Mu, J. (2015) · Kidney & Blood Pressure Research · doi:10.1159/000368536 · Cited by 18 · see citing works

Overexpression of kidney neutral endopeptidase (EC 3.4.24.11) and renal function in experimental cirrhosis

Sansoe, G. G., Aragno, M., Mastrocola, R., Cutrìn, J. C., Silvano, S., Mengozzi, G., Smedile, A., Rosina, F., Danni, O., & Rizzetto, M. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00435.2005 · Cited by 17 · see citing works

Comparative randomized study on efficacy of losartan versus propranolol in lowering portal pressure in decompensated chronic liver disease

Agasti, A., Mahajan, A. U., Phadke, A., Nathani, P. J., & Sawant, P. D. (2012) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12025 · Cited by 16 · see citing works

Tissue distribution of CysAP activity and its relationship to blood pressure and water balance

Prieto, I., Villarejo, A. B., Segarra, A. B., Wangensteen, R., Banegas, I., Marc De Gasparo, B., Vanderheyden, P., Zórad, Š., Vives, F., & Ramírez‐Sánchez, M. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.04.023 · Cited by 16 · see citing works

THE ETIOLOGY OF HYPERTENSION DUE TO COMPLETE RENAL ISCHEMIA

Prinzmetal, M., Lewis, H. A., & Leo, S. D. (1940) · The Journal of Experimental Medicine · doi:10.1084/jem.72.6.763 · Cited by 16 · see citing works

Significance of intracellular free calcium and magnesium and calcium-regulating hormones with sodium chloride loading in patients with essential hypertension

Shingu, T., Matsuura, H., Kusaka, M., Inoue, I., Yuasa, A., Shingu, T., Ishida, T., & Kajiyama, G. (1991) · Journal of Hypertension · doi:10.1097/00004872-199111000-00007 · Cited by 16 · see citing works

Role of the neutral endopeptidase 24.11 in the conversion of big endothelins in guinea‐pig lung parenchyma

Lebel, N., D’Orléans-Juste, P., Fournier, A., & Sirois, P. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15172.x · Cited by 16 · see citing works

Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data

Sansoe, G. G., Aragno, M., Mastrocola, R., Mengozzi, G., Novo, E., & Parola, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162644 · Cited by 14 · see citing works

Calcium-dependent diuretic system in preascitic liver cirrhosis

Sansoe, G. G., Aragno, M., Tomasinelli, C. E., di Bonzo, L. V., Wong, F. S.-H., & Parola, M. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.021 · Cited by 13 · see citing works

Serum pyroglutamyl aminopeptidase activity: a promising novel biomarker candidate for liver cirrhosis

Megias, M. J., Alba-Araguez, F., Luna, J. D. D., Vives, F., & Ramirez-Sanchez, M. (2015) · Endocrine Regulations · doi:10.4149/endo_2015_01_20 · Cited by 12 · see citing works

Is the renin–angiotensin system actually hypertensive?

Bérard, E., Niel, O., & Rubio, A. (2013) · Pediatric Nephrology · doi:10.1007/s00467-013-2481-0 · Cited by 12 · see citing works

Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis

Sansoe, G. G., Silvano, S., Mengozzi, G., Todros, L., Smedile, A., Touscoz, G. A., Rosina, F., & Rizzetto, M. (2003) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.010 · Cited by 12 · see citing works

Natriuretic and aquaretic effects of intravenously infused calcium in preascitic human cirrhosis: physiopathological and clinical implications

Sansoe, G. G., & Wong, F. S.-H. (2007) · Gut · doi:10.1136/gut.2006.109728 · Cited by 12 · see citing works

Endothelin-1 (1-31) induces a thiorphan-sensitive release of eicosanoids via ETB receptors in the guinea pig perfused lung

Plante, M., Honoré, J., Neugebauer, W. A., & D’Orléans-Juste, P. (2002) · Clinical Science · doi:10.1042/cs103s128s · Cited by 11 · see citing works

The Never-ending Story of Angiotensin Peptides

Dell’Italia, L. J., & Ferrario, C. M. (2013) · Circulation Research · doi:10.1161/circresaha.113.301246 · Cited by 11 · see citing works

CIRCULATING LEVELS OF ACTIVE, TOTAL AND INACTIVE RENIN (PRORENIN), ANGIOTENSIN I AND ANGIOTENSINOGEN IN CARBON TETRACHLORIDE‐TREATED RATS

Cruz, C., Ibarra‐Rubio, M. E., & Pedraza‐Chaverrí, J. (1993) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1993.tb00579.x · Cited by 10 · see citing works

Angiotensin II and JAK2 put on the pressure

Bernstein, K. E., & Fuchs, S. (2010) · Nature Medicine · doi:10.1038/nm0210-165 · Cited by 10 · see citing works

The Angiotensin II Receptor Antagonist Candesartan Is Not Effective in Reducing Portal Hypertension in Patients with Cirrhosis

Heim, M. H., Jacob, L., & Beglinger, C. (2007) · Digestion · doi:10.1159/000104819 · Cited by 8 · see citing works

Angiotensin II receptor blockers for the treatment of portal hypertension in patients with liver cirrhosis: a systematic review and meta-analysis of randomized controlled trials

Yao, H., & Zhang, C. (2018) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-018-1765-6 · Cited by 8 · see citing works

Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis.

Yt, T., Hc, L., Fy, L., Mc, H., Wang, S., & Sd, L. (1996) · PubMed · Cited by 7 · see citing works

Influence of miR-26b on hepatic cirrhosis and portal pressure in rats with cirrhotic portal hypertension by targeting hENT1 depending on RhoA/ROCK-1 pathway.

Chen, Y., & Tian, Y. (2019) · PubMed · doi:10.26355/eurrev_201902_17128 · Cited by 4 · see citing works

Su1559 - Tissue Renin-Angiotensin System in the Kidney of Ascitic Cirrhosis: An Innocent Bystander or a Protagonist?

Sansoe, G. G., Aragno, M., Mastrocola, R., & Parola, M. (2018) · Gastroenterology · doi:10.1016/s0016-5085(18)33900-3 · Cited by 2 · see citing works

805 - Impaired Secretion of Renalase into Blood may Lead to Sympathetic Overactivity and Early Sodium Retention in Experimental Liver Cirrhosis

Sansoe, G. G., Aragno, M., Mastrocola, R., & Parola, M. (2018) · Gastroenterology · doi:10.1016/s0016-5085(18)33682-5 · Cited by 1 · see citing works

Renin–angiotensin system: Basic and clinical aspects—A general perspective

Vargas, R., Millán, J. M. V., & Bonilla, E. F. (2021) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2021.05.012 · Cited by 70 · see citing works

Newly discovered endocrine functions of the liver

Rhyu, J., & Yu, R. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i11.1611 · Cited by 62 · see citing works

Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System

Yang, M., Ma, X., Xuan, X., Deng, H., Chen, Q., & Li, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00432 · Cited by 60 · see citing works

Renin–angiotensin–aldosterone pathway modulators in chronic kidney disease: A comparative review

Alshahrani, S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1101068 · Cited by 57 · see citing works

COVID-19-associated liver injury: from bedside to bench

Li, D., Ding, X., Xie, M., Tian, D., & Xia, L. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01760-9 · Cited by 53 · see citing works

The association between hypertension and nonalcoholic fatty liver disease (NAFLD): literature evidence and systems biology analysis

Ma, C., Yan, K., Wang, Z., Zhang, Q., Gao, L., Xu, T., Sai, J., Cheng, F., & Du, Y. (2021) · Bioengineered · doi:10.1080/21655979.2021.1933302 · Cited by 53 · see citing works

Metabolic Dysfunction-Associated Steatotic Liver Disease is Associated with Increased Risks of Heart Failure

Chang, K.-C., Su, T., Wu, C., Huang, S., Tseng, T., Hong, C., Hsu, S., Liu, C., Yang, H., Liu, C., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3567 · Cited by 53 · see citing works

Renin–angiotensin system: Basic and clinical aspects—A general perspective

Vargas Vargas, R. A., Varela Millán, J. M., & Fajardo Bonilla, E. (2022) · Endocrinología, Diabetes y Nutrición (English ed.) · doi:10.1016/j.endien.2022.01.005 · Cited by 51 · see citing works

Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms

Xu, C., Ha, X., Yang, S., Tian, X., & Jiang, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1232790 · Cited by 54 · see citing works

The mechanisms of renin–angiotensin system in hepatocellular carcinoma: From the perspective of liver fibrosis, HCC cell proliferation, metastasis and angiogenesis, and corresponding protection measures

Zhang, H., Gao, X., Wang, X., Chen, X., Huang, Y., Wang, L., & Xu, Z.-W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111868 · Cited by 49 · see citing works

Integrated spatially resolved metabolomics and network toxicology to investigate the hepatotoxicity mechanisms of component D of Polygonum multiflorum Thunb

Jiang, H., Gao, H., Li, J., Zhou, T., Wang, S., Yang, J.-B., Hao, R., Pang, F., Wei, F., Liu, Z., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115630 · Cited by 48 · see citing works

The Renin–Angiotensin System in Liver Disease

McGrath, M. S., & Wentworth, B. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115807 · Cited by 45 · see citing works

COVID‐19 and Liver Cirrhosis: Focus on the Nonclassical Renin‐Angiotensin System and Implications for Therapy

Sansoe, G. G., Aragno, M., & Wong, F. S.-H. (2021) · Hepatology · doi:10.1002/hep.31728 · Cited by 40 · see citing works

Renin–Angiotensin System in Liver Metabolism: Gender Differences and Role of Incretins

Mastoor, Z., Diz-Chaves, Y., González-Matías, L. C., & Mallo, F. (2022) · Metabolites · doi:10.3390/metabo12050411 · Cited by 32 · see citing works

Cathepsins in the extracellular space: Focusing on non-lysosomal proteolytic functions with clinical implications

Wang, H., Inoue, A., Lei, Y., Wu, H., Hong, L., & Cheng, X. W. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110531 · Cited by 31 · see citing works

Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges

Ali, F. E. M., Mohammedsaleh, Z. M., Ali, M., & Ghogar, O. M. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i15.1531 · Cited by 29 · see citing works

The classical and non-classical axes of renin-angiotensin system in Parkinson disease: The bright and dark side of the moon

Al-Kuraishy, H. M., Al-Hamash, S. M., Jabir, M. S., Al-Gareeb, A. I., Albuhadily, A. K., Albukhaty, S., & Sulaiman, G. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102200 · Cited by 27 · see citing works

Chrysin Attenuates Fructose‐Induced Nonalcoholic Fatty Liver in Rats via Antioxidant and Anti‐Inflammatory Effects: The Role of Angiotensin‐Converting Enzyme 2/Angiotensin (1‐7)/Mas Receptor Axis

Attia, H., Albekairi, N. A., Albdeirat, L., Soliman, A., Rajab, R., Alotaibi, H., Ali, R., & Badr, A. M. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9479456 · Cited by 26 · see citing works

The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes

Hartl, L., Jachs, M., Desbalmes, C., Schaufler, D., Simbrunner, B., Paternostro, R., Schwabl, P., Bauer, D. J. M., Semmler, G., Scheiner, B., et al. (2021) · Hepatology International · doi:10.1007/s12072-021-10203-9 · Cited by 24 · see citing works

The systemic and hepatic alternative renin–angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation

Hartl, L., Rumpf, B., Domenig, O., Simbrunner, B., Paternostro, R., Jachs, M., Poglitsch, M., Marculescu, R., Trauner, M. A., Reindl‐Schwaighofer, R., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-28239-2 · Cited by 19 · see citing works

Angiotensin-converting enzyme 2 improves hepatic insulin resistance by regulating GABAergic signaling in the liver

Chen, Q., Gao, Y., Yang, F., Deng, H., Wang, Y., & Li, Y. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102603 · Cited by 18 · see citing works

ACE2: A Linkage for the Interplay Between COVID-19 and Decompensated Cirrhosis

Gao, F., Zheng, K. I., Fan, Y., Targher, G., Byrne, C. D., & Zheng, M. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000780 · Cited by 18 · see citing works

The Role of High Fat Diets and Liver Peptidase Activity in the Development of Obesity and Insulin Resistance in Wistar Rats

Domínguez-Vías, G., Segarra, A. B., Ramírez‐Sánchez, M., & Prieto, I. (2020) · Nutrients · doi:10.3390/nu12030636 · Cited by 17 · see citing works

An impaired pituitary–adrenal signalling axis in stable cirrhosis is linked to worse prognosis

Hartl, L., Simbrunner, B., Jachs, M., Wolf, P. S., Bauer, D. J. M., Scheiner, B., Balcar, L., Semmler, G., Schwarz, M., Marculescu, R., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100789 · Cited by 17 · see citing works

New Viral Diseases and New Possible Remedies by Means of the Pharmacology of the Renin-Angiotensin System

Sansoe, G. G., & Aragno, M. (2023) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1155/2023/3362391 · Cited by 17 · see citing works

Inflammasome as an Effective Platform for Fibrosis Therapy

Chen, T., Xiao, F., Li, N., Shan, S., Qi, M., Wang, Z., Zhang, S., Wei, W., & Sun, W. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s304180 · Cited by 17 · see citing works

Activatable self-assembled organic nanotheranostics: Aspartyl aminopeptidase triggered NIR fluorescence imaging-guided photothermal/photodynamic synergistic therapy

Zhao, C., Liu, W., Sun, W., Yu, H., Sheng, Z., Wang, J., Jiang, Y., & Liu, Y. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.340198 · Cited by 16 · see citing works

The clinical course and prognostic factors of severe COVID-19 in Wuhan, China

Liu, J., Tu, C., Zhu, M., Wang, J., Yang, C., Liu, W. Y., & Xiong, B. (2021) · Medicine · doi:10.1097/md.0000000000023996 · Cited by 16 · see citing works

Could protein content of Urinary Extracellular Vesicles be useful to detect Cirrhosis in Alcoholic Liver Disease?

González, E., Azkargorta, M., Garcia‐Vallicrosa, C., Elordui, J. P., Elortza, F., Blanco-Sampascual, S., & Falcón‐Pérez, J. M. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59725 · Cited by 16 · see citing works

Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19

Hartl, L., Jachs, M., Simbrunner, B., Bauer, D. J. M., Semmler, G., Gompelmann, D., Szekeres, T., Quehenberger, P., Trauner, M. A., Mandorfer, M., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121264 · Cited by 14 · see citing works

Transplantation of human umbilical cord-derived mesenchymal stem cells improves age-related ovarian functional decline via regulating the local renin–angiotensin system on inflammation and oxidative stress

Wei, L., Bo, L., Luo, C., Yin, N., Jiang, W., Qian, F., Zhou, A., Lu, X., Guo, H., & Mao, C. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03997-6 · Cited by 11 · see citing works

Serpina3c protects against metabolic dysfunction-associated steatotic liver disease in offspring induced by prenatal prednisone exposure

Dai, Y., Lu, Z., Peng, Y., Liu, K., Lu, X., Sun, X., Wang, Y., Yan, X., Chen, Z., Zhang, Z., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02569-1 · Cited by 11 · see citing works

Proteomic signature of metabolic dysfunction-associated steatotic liver disease and risk of atherosclerotic cardiovascular disease

Pan, L., Shen, M., Liu, Y., Huang, C., Lin, R., Qin, G., & Yu, Y. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03034-7 · Cited by 10 · see citing works

Possible role of LCZ696 in atherosclerosis: new inroads and perspective

Al-Kuraishy, H. M., Al-Gareeb, A. I., Elekhnawy, E., & Batiha, G. E. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04816-x · Cited by 9 · see citing works

Neuroprotective Effects of Casein-Derived Peptide Met-Lys-Pro (MKP) in a Hypertensive Model

Tada, A., Hamezah, H. S., Yanagisawa, D., Morikawa, S., & Tooyama, I. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00845 · Cited by 9 · see citing works

Recent insights into contributing factors in the pathogenesis of cirrhotic ascites

Li, Z., Zhu, J., & Ouyang, H. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1376217 · Cited by 8 · see citing works

Unlocking the potential of the ACE2 /Ang‐(1–7)/Mas Axis in liver diseases: From molecular mechanisms to translational applications

Yang, J., Yang, Y., Tan, X., Du, H., Zhou, Z., Chen, L., Tian, X., Zheng, G., Hu, J., Zhang, C., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16435 · Cited by 7 · see citing works

Interaction of Serum Alkaline Phosphatase and Folic Acid Treatment on Chronic Kidney Disease Progression in Treated Hypertensive Adults

Zhang, Y., He, P., Wang, G., Liang, M., Xie, D., Nie, J., Liu, C., Song, Y., Liu, L., Wang, B., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.753803 · Cited by 7 · see citing works

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease Cross Talk

Nysather, J. A., Kaya, E., Manka, P. P., Gudsoorkar, P. S., & Syn, W. (2023) · Advances in Kidney Disease and Health · doi:10.1053/j.akdh.2023.04.001 · Cited by 7 · see citing works

Differential Roles of Angiotensin A and Alamandine in Parkinson's Disease: A Therapeutic Perspective on Nonclassical RAS Pathways

Alshehri, G. H., Al-Kuraishy, H. M., Albuhadily, A. K., Al-Gareeb, A. I., Aboutaleb, A. S., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · Brain and Behavior · doi:10.1002/brb3.70721 · Cited by 5 · see citing works

Effects of renin–angiotensin inhibitors on renal function and the clinical course in patients with decompensated cirrhosis

Tergast, T. L., Griemsmann, M., Wedemeyer, H. H., Cornberg, M., & Maasoumy, B. (2023) · Scientific Reports · doi:10.1038/s41598-023-44299-w · Cited by 5 · see citing works

Pseudohypoadrenalism, a subclinical cortisol metabolism disorder in hyperuricemia

Bao, R., Chen, B., Pan, J., Wang, A. Z., Yu, H., Chen, Q., Zhang, Y., & Wang, T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1279205 · Cited by 4 · see citing works

Galaxaura elongata Extract (GE) Modulates Vanadyl Sulfate-Induced Renal Damage via Regulating TGF-β/Smads and Nrf2/NF-κB Pathways

Kamel, A. K. A., Hozayen, W. G., Abdel-Kawi, S. H., & Hashem, K. S. (2021) · Biological Trace Element Research · doi:10.1007/s12011-021-02913-w · Cited by 4 · see citing works

A Golden Shield: The Protective Role of Curcumin against Liver Fibrosis

Abolfazli, S., Butler, A. E., Jamialahmadi, T., & Sahebkar, A. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230821095329 · Cited by 4 · see citing works

Angiotensin-converting enzyme inhibitory peptide IVGFPAYGH protects against liver injury in mice fed a high‑sodium diet by inhibiting the RAS and remodeling gut microbial communities

Zou, L., Yu, X., Cai, K., Xu, B., Chen, C., & Xiao, G. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128265 · Cited by 4 · see citing works

The impact of COVID-19 on the clinical outcome of patients with cirrhosis deserves more attention and research

Gao, F., & Huang, Z.-M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.06.024 · Cited by 3 · see citing works

The regulatory role of the renin-angiotensin system in the tumor microenvironment and immunotherapy of hepatocellular carcinoma

Qu, Z., & Wang, X. (2026) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/14703203251409639 · Cited by 2 · see citing works

Role of Renin-Angiotensin System in the Pathogenesis and Progression of Non-alcoholic Fatty Liver

Badr, A. M., Sherif, I. O., Mahran, Y. F., & Attia, H. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-23621-1_10 · Cited by 2 · see citing works

Partial Replacement of NaCl with KCl in Cooked Meat Could Reduce the Liver Damage Through Renin–Angiotensin System in Mice

Zou, L., Yu, X., Xiong, J.-H., Chen, C., & Xiao, G. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200783 · Cited by 2 · see citing works

Can Plasma Volume Determination in Cirrhosis Be Replaced by an Algorithm Using Body Weight and Hematocrit?

Nørskov, M. P., Mønsted, T., Kimer, N., Damgaard, M., & Møller, S. (2024) · Diagnostics · doi:10.3390/diagnostics14080835 · Cited by 2 · see citing works

Neuritogenesis and protective effects activated by Angiotensin 1–7 in astrocytes-neuron interaction

Barbosa, G. A. D. C., Rubinho, M. P., Júnior, M. K. A., Pedro, J. R., Donato, L. F., Trisciuzzi, L., Silva, A. O., Ruginsk, S. G., Ceron, C. S., Peixoto, N., et al. (2024) · Neuropeptides · doi:10.1016/j.npep.2024.102480 · Cited by 2 · see citing works

Preascitic Sodium Retention in Cirrhosis: A Role for Disregulated Proteolysis by Proprotein Convertases?

Sansoe, G. G., Aragno, M., & Wong, F. S.-H. (2025) · Liver international communications. · doi:10.1002/lci2.70020 · Cited by 1 · see citing works

Cholesterol uptake capacity of HDL in culture medium of fresh primary human hepatocytes: an in vitro system for screening anti-atherosclerosis drugs focused on HDL functions

Hata, K., Okada, T., Takahashi, M., Arimatsu, Y., Kawahira, J., Murakami, K., Harada, A., Yoshikawa, N., Inamatsu, M., & Kakuni, M. (2025) · BMC Research Notes · doi:10.1186/s13104-025-07515-6 · Cited by 1 · see citing works

The Classical and Nonclassical Renin-Angiotensin-Aldosterone System in Liver Cirrhosis

Sansoe, G. G., & Wong, F. S.-H. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-23621-1_11 · Cited by 1 · see citing works

Impact of long-term continuous terlipressin infusion on the renin-angiotensin-aldosterone system in patients with decompensated cirrhosis

Terbah, R., Hoermann, R., Grace, J., Burrell, L. M., Patel, S. K., Testro, A., Majumdar, A., & Sinclair, M. J. (2025) · Frontline Gastroenterology · doi:10.1136/flgastro-2025-103161 · Cited by 1 · see citing works

Could Protein Content of Urinary Extracellular Vesicles be Useful to Detect Alcoholic Liver Disease and Assess Hepatocarcinoma Risk?Preprint

González, E., Azkargorta, M., Garcia‐Vallicrosa, C., Elordui, J. P., Elortza, F., Blanco-Sampascual, S., & Falcón‐Pérez, J. M. (2021) · Preprints.org · doi:10.20944/preprints202102.0069.v1 · Cited by 1 · see citing works

Association of the Renin-Angiotensin System Components in Human Follicular Fluid with Age, Ovarian Function and IVF Outcome: A Cross-Sectional StudyPreprint

Wei, L., Bo, L., Zhou, A., Luo, C., Wu, Z., Lu, X., Zhan, L., Gao, S., Qian, F., & Mao, C. (2022) · Research Square · doi:10.21203/rs.3.rs-2368217/v1

Reply

Elhence, H., Dodge, J. L., & Lee, B. P. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.03.044

Transplantation of mesenchymal stem cells improves age-related ovarian dysfunction via regulating the local renin-angiotensin systemPreprint

Mao, C., Wei, L., Guo, H., Luo, C., Yin, N., Jiang, W., Qian, F., Zhou, A., Lu, X., & Bo, L. (2024) · Research Square · doi:10.21203/rs.3.rs-4569611/v1

Elevated Serum Renin Before Liver Transplantation Is Associated With Increased Intraoperative Vasopressor Requirements and Posttransplant Acute Kidney Injury

Hilaire, L. S., Tran, A. T., Kothari, R. P., Adelmann, D., Hellman, J., & Bokoch, M. P. (2026) · Transplantation · doi:10.1097/tp.0000000000005877 · Cited by 1 · see citing works

Animal collagen as a source of antihypertensive bioactive peptides: production technologies, structural characteristics, and molecular mechanisms

Laosam, P., Purba, R. A. P., Katemala, S., Suwanangul, S., Aenglong, C., Pongsamai, N., Yue, Y., Pinyo, J., & Sangsawad, P. (2026) · Collagen and Leather · doi:10.1186/s42825-026-00265-6

Renin-angiotensin system and progression of chronic liver diseases

Yamamoto, S. (2006)

Local renin–angiotensin system in the kidney of ascitic cirrhosis: An innocent bystander or a major protagonist?

Sansoe, G. G., Aragno, M., Mastrocola, R., Ayoubi, M., & Parola, M. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.01.043

Renin angiotensin system in liver diseases: Friend or foe?

Silva, A. C. S. E., de Miranda, A. S., Rocha, N. P., & Teixeira, A. L. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i19.3396 · Cited by 101 · see citing works

Update on new aspects of the renin–angiotensin system in liver disease: clinical implications and new therapeutic options

Grace, J., Herath, C. B., Mak, K. Y., Burrell, L. M., & Angus, P. (2012) · Clinical Science · doi:10.1042/cs20120030 · Cited by 101 · see citing works

The Classical and Nonclassical Renin-Angiotensin-Aldosterone System in Liver Cirrhosis

Sansoe, G. G., & Wong, F. S.-H. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-23621-1_11 · Cited by 1 · see citing works